tiprankstipranks
Phibro Animal Health Expands Portfolio with Zoetis Acquisition
Company Announcements

Phibro Animal Health Expands Portfolio with Zoetis Acquisition

Don't Miss Our Christmas Offers:

Phibro Animal Health (PAHC) just unveiled an announcement.

Phibro Animal Health Corporation has struck a deal to acquire Zoetis Inc.’s medicated feed additive and water soluble product lines, with the transaction including the purchase of equity interests in Zoetis Medolla and Zoetis Suzhou. The $350 million deal, subject to adjustments, will be financed primarily through a $325 million debt facility arranged with Rabobank, Compeer, and Citibank, alongside potential balance sheet cash. The acquisition is dependent on standard regulatory approvals and the fulfillment of other customary closing conditions.

For a thorough assessment of PAHC stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyPhibro Animal Health price target raised to $25 from $20 at Morgan Stanley
TipRanks Auto-Generated NewsdeskPhibro Animal Health Announces Leadership Transition Plans
TheFlyPhibro Animal Health price target raised to $20 from $13 at Barclays
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App